Oncogene c-Myc promotes epitranscriptome m(6)A reader YTHDF1 expression in colorectal cancer

Recent studies that have emerged on the diversity of RNA modification in tumors suggest their eligibility as bona fide targets in diagnosis and drug discovery. N6-methyladenosine (m(6)A) was first reported and is most common in epitranscriptome modification of various RNAs. The YT521-B homology (YTH...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishizawa, Yujiro, Konno, Masamitsu, Asai, Ayumu, Koseki, Jun, Kawamoto, Koichi, Miyoshi, Norikatsu, Takahashi, Hidekazu, Nishida, Naohiro, Haraguchi, Naotsugu, Sakai, Daisuke, Kudo, Toshihiro, Hata, Taishi, Matsuda, Chu, Mizushima, Tsunekazu, Satoh, Taroh, Doki, Yuichiro, Mori, Masaki, Ishii, Hideshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800917/
https://www.ncbi.nlm.nih.gov/pubmed/29484125
http://dx.doi.org/10.18632/oncotarget.23554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800917/
https://www.ncbi.nlm.nih.gov/pubmed/29484125
http://dx.doi.org/10.18632/oncotarget.23554

Ejemplares similares